A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 61
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : SAB
Long Form : S. aureus bacteremia
No. Year Title Co-occurring Abbreviation
2019 Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia. ASPs, CIs, GRADE, NOS, RRs
2019 Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus. BMD, MICs, MRSA, S. aureus, VAN
2018 Human Genetic Susceptibility to Native Valve Staphylococcus aureus Endocarditis in Patients With S. aureus Bacteremia: Genome-Wide Association Study. GWAS, SAIE, SNPs
2018 Incidence and Outcomes of Staphylococcus aureus Bacteriuria: A Population-based Study. SABU
2018 Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis. CI, MRSA, MSSA, OR
2018 Staphylococcus aureus Bacteremia Incidence and Methicillin Resistance in Rural Thailand, 2006-2014. CI, CO, HO, MRSA
2018 The clinical significance of concomitant bacteriuria in patients with Staphylococcus aureus bacteremia. A review and meta-analysis. SABU
2017 A 5-year Survey Reveals Increased Susceptibility to Glycopeptides for Methicillin-Resistant Staphylococcus aureus Isolates from Staphylococcus aureus Bacteremia Patients in a Chinese Burn Center. MRSA
2017 Bacteremia, Sepsis, and Infective Endocarditis Associated with Staphylococcus aureus. IE
10  2017 Ceftaroline for the treatment of methicillin-resistant Staphylococcus aureus bacteremia. ABSSSIs, CABP, MRSAB
11  2017 Clinical presentation, management and outcomes of Staph aureus bacteremia (SAB) in older adults. TEE
12  2017 Hospital-associated methicillin-resistant Staphylococcus aureus: A cross-sectional analysis of risk factors in South African tertiary public hospitals. AOR, CI, HA-MRSA
13  2017 Increased Endovascular Staphylococcus aureus Inoculum Is the Link Between Elevated Serum Interleukin 10 Concentrations and Mortality in Patients With Bacteremia. IL-10
14  2017 Molecular epidemiology of Staphylococcus aureus bacteremia in a single large Minnesota medical center in 2015 as assessed using MLST, core genome MLST and spa typing. CCs, cgMLST, MLST, MRSA, MSSA, SPA, STs, WGS
15  2016 Genotypic and phenotypic analysis of clinical isolates of Staphylococcus aureus revealed production patterns and hemolytic potentials unlinked to gene profiles and source. ---
16  2016 Increased Age-Dependent Risk of Death Associated With lukF-PV-Positive Staphylococcus aureus Bacteremia. ---
17  2016 Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study. CCI, HR, ICU, MRSA
18  2016 Prevalence and Clinical Impact of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolated From Hospitalized Patients. GRD, hVISA
19  2016 Rapid, Culture-Free Detection of Staphylococcus aureus Bacteremia. ---
20  2016 Relationship between pathogenic, clinical, and virulence factors of Staphylococcus aureus in infective endocarditis versus uncomplicated bacteremia: a case-control study. agr, etA, IE, MIC, PCR, SA, SAg, tst-1, un-BAC
21  2015 Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia. RBC
22  2015 Comparison of Outcomes among Adult Patients with Nosocomial Bacteremia Caused by Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus: A Retrospective Cohort Study. MRSA, MSSA, SCCmec
23  2015 Low mortality of Staphylococcus aureus bacteremia in Icelandic children: nationwide study on incidence and outcome. ---
24  2015 Multicenter study of health care cost of patients admitted to hospital with Staphylococcus aureus bacteremia: Impact of length of stay and intensity of care. MRSA, MSSA
25  2015 Polymorphisms in Fibronectin Binding Proteins A and B among Staphylococcus aureus Bloodstream Isolates Are Not Associated with Arthroplasty Infection. fnbA, SNPs
26  2015 Prevalence and Trends of Staphylococcus aureus Bacteraemia in Hospitalized Patients in South Africa, 2010 to 2012: Laboratory-Based Surveillance Mapping of Antimicrobial Resistance and Molecular Epidemiology. MLST
27  2015 Staphylococcus aureus bacteraemia in Gauteng academic hospitals, South Africa. CI, MRSA, MSSA, OR
28  2015 Staphylococcus aureus Bacteremia in Children: Changes During Eighteen Years. MRSA
29  2014 A genome-wide association study of variants associated with acquisition of Staphylococcus aureus bacteremia in a healthcare setting. GWAS
30  2014 A recommendation to perform a blood culture before the administration of intravenous antibiotics increased the detection of Staphylococcus aureus bacteremia. AST, spa
31  2014 Bone and joint infection as a predictor of community-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a comparative cohort study. CA-MRSA, CA-MSSA, PVL, SCCmec, ST
32  2013 Decreasing incidence of Staphylococcus aureus bacteremia over 9 years: greatest decline in community-associated methicillin-susceptible and hospital-acquired methicillin-resistant isolates. CA-MRSA
33  2013 Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis. HRs
34  2013 Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia. AUC/MIC, BMD
35  2012 Clinical significance of Staphylococcus aureus bacteriuria in a nationwide study of adults with S. aureus bacteraemia. SABU
36  2012 Genetic variability in beta-defensins is not associated with susceptibility to Staphylococcus aureus bacteremia. CA-SAB, PPRT
37  2012 Incidence and risk factors for endocarditis among patients with health care-associated Staphylococcus aureus bacteraemia. CI, IE, OR
38  2012 sarA-mediated repression of protease production plays a key role in the pathogenesis of Staphylococcus aureus USA300 isolates. sarA
39  2012 Treatment of community-onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: a hospital-based study. CCI, CNS, MRSA
40  2011 Characterization of infecting strains and superantigen-neutralizing antibodies in Staphylococcus aureus bacteremia. IDUs, non-egc, SAgs
41  2011 Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography. IE
42  2011 Preventing Staphylococcus aureus bacteremia and sepsis in patients with Staphylococcus aureus colonization of intravascular catheters: a retrospective multicenter study and meta-analysis. CI, OR
43  2010 Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges. MRSA
44  2010 Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of MRSA. MRSA, MSSA
45  2009 Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. CI, MRSA, MSSA, ORs
46  2009 Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis. SIRS
47  2009 The association between Staphylococcus aureus bacteremia and acute myocardial infarction. MI
48  2009 The clinical significance of concurrent Staphylococcus aureus bacteriuria in patients with S. aureus bacteremia. IDUC, SABU
49  2008 High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia. MIC, PFGE
50  2008 Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. MSSA-B
51  2008 [Epidemiology, course and prognosis of Staphylococcus aureus bacteremia--Preliminary results from the INSTINCT (INvasive STaphylococcus aureus INfection CohorT) cohort]. INSTINCT
52  2007 Analysis of methicillin resistance among Staphylococcus aureus blood isolates in an emergency department. ED, MRSA
53  2007 Changing epidemiology of pediatric Staphylococcus aureus bacteremia in Denmark from 1971 through 2000. ---
54  2007 Risk factors for infective endocarditis and outcome of patients with Staphylococcus aureus bacteremia. CI, OR, SAIE
55  2006 Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. CCE
56  2005 Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. MRSA, MSSA
57  2005 Healthcare-associated Staphylococcus aureus bacteremia and the risk for methicillin resistance: is the Centers for Disease Control and Prevention definition for community-acquired bacteremia still appropriate? CDC, MRSA, PFGE
58  2005 Importance of transesophageal echocardiography in the evaluation of Staphylococcus aureus bacteremia. TEE
59  2003 Staphylococcus aureus bacteremia and endocarditis. IE
60  2002 Staphylococcus aureus bacteremia and endocarditis. IE
61  2001 Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. HIV